Basic info
Industry
biotechnology research
Sectors
Biotechnology
BBB
Hunter syndrome
MLD
LSDs
CNS
Mucopolysaccharidosis 1
Mucopolysaccharidosis 2
Health Care
Hurler syndrome
Blood-Brain barrier
Metachromatic leukodystrophy
MPS 2
MPS 1
AGT-182
AGT-181
Lysosomal storage diseases
Medical
AGT-184
AGT-183
Date founded
2003
Funding rounds raised
Total raised
$17M
from 2 investors over 2 rounds
A
ArmaGen Pharmaceuticals raised $17M on November 29, 2012
Investors: Takeda UK Limited and Shire Pharmaceuticals